|Bid||14.02 x 1000|
|Ask||15.27 x 3200|
|Day's Range||14.06 - 14.85|
|52 Week Range||13.53 - 22.22|
|Beta (5Y Monthly)||1.07|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 04, 2021 - Aug 09, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.25|
In the past three years, the share price of Coherus BioSciences, Inc. ( NASDAQ:CHRS ) has struggled to generate growth...
REDWOOD CITY, Calif., May 07, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the upcoming Bank of America Health Care Conference on Wednesday, May 12, 2021 at 1:15 p.m. EST / 10:15 a.m. PST. The audio portion of the Company presentation will be available on the investors page of the Coherus BioSciences website at https://investors.coherus.com. About Coherus BioSciencesCoherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. For additional information, please visit www.coherus.com. Contact McDavid StilwellCFOCoherus BioSciences, Inc.email@example.com+1 (650) 395-0152
Image source: The Motley Fool. Coherus BioSciences Inc (NASDAQ: CHRS)Q1 2021 Earnings CallMay 6, 2021, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to the Q1 2021 Coherus BioSciences, Inc.